DIA Biosimilars 2013

Study Conduct

PRA International Opens Phase I Facility in Hungary

Friday, July 2, 2010 08:03 AM

PRA International, a global CRO, opened a phase I facility in Budapest, Hungary that will provide “unit-on-demand” service.

More... »

Cenduit: Now with Patient Reminders

BBK Introduces Patient Recruitment Franchise Program

Friday, June 25, 2010 08:55 AM

BBK Worldwide expanded its three decades of expertise in supporting clinical R&D with the introduction of its patient recruitment franchise program at the DIA Annual Meeting in Washington, D.C.

More... »

CRF Health – eCOA Forum

SAFE-BioPharma Signing up Sites, CROs

Wednesday, June 23, 2010 08:48 AM

Contract research organizations (CROs) and investigative sites have begun to adopt SAFE-BioPharma digital identities, which are already widely used by biopharmaceutical companies, in order to sign contracts and other clinical trial documents electronically.

More... »

Merck Launches Oncology Network, Reduces Sites

Thursday, June 17, 2010 09:14 AM

In an effort to streamline its cancer research, Merck has launched the Merck Oncology Collaborative Trials Network, a collection of key oncology-focused investigative sites around the world with which Merck will work exclusively on promising compounds during early phases.

More... »

Medical Research Funding at Baylor Still Strong

Wednesday, June 16, 2010 09:30 AM

The Baylor Institute of Immunology Research (BIIR), a component of Baylor Research Institute, received grants totaling nearly $35 million in 2009, despite an economy that's seen a marked decrease in charitable giving and government grants.

More... »

Combined Industry Trial Data on Alzheimer's Disease Made Widely Available to Researchers

Tuesday, June 15, 2010 08:41 AM

A new database of more than 4,000 Alzheimer's disease patients who have participated in 11 industry-sponsored clinical trials was released by the Coalition Against Major Diseases.

More... »

Site-less, PI-less Trials?

Thursday, June 10, 2010 08:58 AM

Quincy Bioscience just may be on to something. The Madison, Wis.-based maker of the jellyfish-based supplement Prevagen has just launched a portal that allows most interactions with its study subjects to take place exclusively online.

More... »

Clinical Research Atlanta Site Adds Phase I/IIa Unit

Wednesday, June 9, 2010 08:55 AM

Clinical Research Atlanta is expanding into phase I and IIa work. The 17-year-old, multi-specialty site just added a 3,500-square-foot building, making it the only Atlanta-area site conducting phase I/IIa work outside of the areas of oncology and psychiatry, and also outside of a hospital or university setting.

More... »

University of North Carolina, Olympus Open Advanced Imaging Center

Monday, June 7, 2010 09:30 AM

The University of North Carolina at Chapel Hill has opened a new facility designed to be one of the world’s most sophisticated research centers devoted to life science imaging. The UNC-Olympus Research Imaging Center provides researchers with advanced equipment, software, consultation and expertise and is designed to stimulate collaboration among top life science research faculty members. It will be available to guest researchers as well.

More... »

CenterWatch Monthly June 2010

Thursday, June 3, 2010 08:38 AM

i3 Research, PPD, Kendle, Covance Rated Top CROs in Europe in 2010

More... »

CenterWatch eBooks
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs